<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23408291</PMID><DateCompleted><Year>2014</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1831</ISSN><JournalIssue CitedMedium="Internet"><Volume>202</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Medical microbiology and immunology</Title><ISOAbbreviation>Med Microbiol Immunol</ISOAbbreviation></Journal><ArticleTitle>Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice.</ArticleTitle><Pagination><StartPage>259</StartPage><EndPage>265</EndPage><MedlinePgn>259-65</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00430-013-0289-y</ELocationID><Abstract><AbstractText>Antibody-dependent enhancement (ADE) of virus infections can be induced by subneutralizing concentrations of specific antibodies. We recently demonstrated ADE in human monocytes infected with enterovirus 71 (EV71). The current study was designed to extend these observations by determining the effect of ADE on the pathogenesis of EV71 infection in newborn mice. We compared the clinical manifestations, mortality, virus titer, histopathology, and serum levels of cytokines and chemokines in newborn mice pretreated with subneutralizing antibodies to EV71 or normal mouse IgG with and without virus. Seven-day-old ICR mice were pretreated with a wide range of mouse anti-EV71 IgG 24 h prior to intraperitoneal injection of EV71. Mice were protected from infection by neutralizing doses of anti-EV71 IgG ranging from 6.43 &#xd7; 10&#x207b;&#xb9; to 329.6 &#x3bc;g/ml. Subneutralizing doses ranging from 2.01 &#xd7; 10&#x207b;&#xb2; to 3.21 &#xd7; 10&#x207b;&#xb9; &#x3bc;g/ml were found to significantly increase 14-day mortality compared to virus alone. The ADE effect was not evident at lower doses. Histopathological examination of mice given a subneutralizing dose of 8.04 &#xd7; 10&#x207b;&#xb2; &#x3bc;g/ml revealed extensive neuronal and muscular damage compared to untreated infected controls. Higher serum levels of interferon (IFN)-&#x3b3; and monocyte chemoattractant protein (MCP)-1 were noted in mice pretreated with subneutralizing doses than untreated infected controls. These findings support the concept that subneutralizing antibodies directed enhance EV71 induce ADE in newborn mice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>I-Chun</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shih-Min</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Chun-Keung</ForeName><Initials>CK</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ching-Chuan</ForeName><Initials>CC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Med Microbiol Immunol</MedlineTA><NlmUniqueID>0314524</NlmUniqueID><ISSNLinking>0300-8584</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019067" MajorTopicYN="Y">Antibody-Dependent Enhancement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006651" MajorTopicYN="N">Histocytochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23408291</ArticleId><ArticleId IdType="doi">10.1007/s00430-013-0289-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin Infect Dis. 1999 Jul;29(1):184-90</Citation><ArticleIdList><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Oct 1;198(7):1002-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18710325</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2003 Aug 15;188(4):564-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1999 Sep 23;341(13):929-35</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2007 Jul;13(7):677-82</Citation><ArticleIdList><ArticleId IdType="pubmed">17441979</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2011 Mar 08;8:106</Citation><ArticleIdList><ArticleId IdType="pubmed">21385398</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2007 May;125(2):183-90</Citation><ArticleIdList><ArticleId IdType="pubmed">17291618</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1989 Nov;160(5):777-82</Citation><ArticleIdList><ArticleId IdType="pubmed">2809253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2009 Jul;15(7):798-801</Citation><ArticleIdList><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1988 Apr 9;1(8589):790-4</Citation><ArticleIdList><ArticleId IdType="pubmed">2895317</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2001 Aug;82(Pt 8):1899-1907</Citation><ArticleIdList><ArticleId IdType="pubmed">11457996</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Anti Infect Ther. 2009 Aug;7(6):735-42</Citation><ArticleIdList><ArticleId IdType="pubmed">19681701</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral Immunol. 2006 Summer;19(3):434-47</Citation><ArticleIdList><ArticleId IdType="pubmed">16987062</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Neonatol. 2008 Aug;49(4):113-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19054915</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust J Exp Biol Med Sci. 1964 Aug;42:465-82</Citation><ArticleIdList><ArticleId IdType="pubmed">14202187</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Vaccine Immunol. 2010 Oct;17(10):1517-23</Citation><ArticleIdList><ArticleId IdType="pubmed">20685937</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Trop Med Hyg. 1988 Mar;38(2):411-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3354774</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):1219-24</Citation><ArticleIdList><ArticleId IdType="pubmed">21983920</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2010 May 7;328(5979):745-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20448183</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Aug;78(15):7916-24</Citation><ArticleIdList><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2010 Feb 12;6(2):e1000790</Citation><ArticleIdList><ArticleId IdType="pubmed">20168989</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2010 Feb 18;7(2):85-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20159612</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2001 Nov 1;184(9):1098-108</Citation><ArticleIdList><ArticleId IdType="pubmed">11598831</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2002 Feb;83(Pt 2):351-358</Citation><ArticleIdList><ArticleId IdType="pubmed">11807228</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1999 Sep 23;341(13):936-42</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1988 Jan;62(1):20-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3334744</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1981 Nov;114(5):632-48</Citation><ArticleIdList><ArticleId IdType="pubmed">6272572</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2006 Mar 1;176(5):2825-32</Citation><ArticleIdList><ArticleId IdType="pubmed">16493039</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 1998 Mar;54(3):210-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9515771</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2009 Apr;15(4):581-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19331737</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2001 Feb;63(2):150-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11170052</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2009 Jul;15(7):794-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1989 Jan;70 ( Pt 1):89-96</Citation><ArticleIdList><ArticleId IdType="pubmed">2732688</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1981 Jan 15;289(5794):189-91</Citation><ArticleIdList><ArticleId IdType="pubmed">7453820</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>